U.S. markets closed

Sarepta Therapeutics, Inc. (SRPT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
67.78-1.17 (-1.70%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
As of Date: 7/31/2021
Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 7

Trading Information

Stock Price History

Beta (5Y Monthly) 1.44
52-Week Change 3-57.16%
S&P500 52-Week Change 333.41%
52 Week High 3181.83
52 Week Low 365.30
50-Day Moving Average 373.83
200-Day Moving Average 379.32

Share Statistics

Avg Vol (3 month) 31.12M
Avg Vol (10 day) 3663.93k
Shares Outstanding 579.77M
Implied Shares Outstanding 6N/A
Float 76M
% Held by Insiders 14.80%
% Held by Institutions 182.90%
Shares Short (Jul 14, 2021) 46.49M
Short Ratio (Jul 14, 2021) 48.11
Short % of Float (Jul 14, 2021) 49.55%
Short % of Shares Outstanding (Jul 14, 2021) 48.14%
Shares Short (prior month Jun 14, 2021) 46.66M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:6
Last Split Date 3Jul 11, 2012

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Mar 30, 2021


Profit Margin -122.77%
Operating Margin (ttm)-102.54%

Management Effectiveness

Return on Assets (ttm)-12.86%
Return on Equity (ttm)-83.78%

Income Statement

Revenue (ttm)573.36M
Revenue Per Share (ttm)7.28
Quarterly Revenue Growth (yoy)29.30%
Gross Profit (ttm)-245.53M
EBITDA -558.59M
Net Income Avi to Common (ttm)-703.89M
Diluted EPS (ttm)-8.94
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.74B
Total Cash Per Share (mrq)21.78
Total Debt (mrq)1.17B
Total Debt/Equity (mrq)218.51
Current Ratio (mrq)6.23
Book Value Per Share (mrq)6.71

Cash Flow Statement

Operating Cash Flow (ttm)-700.69M
Levered Free Cash Flow (ttm)-463.3M